指南与共识眼底病与葡萄膜炎

APVRS、AEEC、APOIS、AAPPO与ARI关于厚玻璃膜疣诊断与管理的国际共识与指南

International Consensus and Guidelines on Diagnosing and Managing Pachydrusen from APVRS, AEEC, APOIS, AAPPO, and ARI.
指南 / 共识 · Am J Ophthalmol · 2025-10-12

国际专家小组系统综述厚玻璃膜疣的形态、诊断标准与临床结局,制定循证共识声明。厚玻璃膜疣为≥125 μm、边界清晰的不规则多小叶黄白色沉积,与脉络膜增厚相关,遗传观察提示其为AMD谱系中独立亚型,但进展至晚期AMD的风险需进一步阐明。

要点

  • 厚玻璃膜疣为≥125 μm、边界清晰的不规则多小叶黄白色沉积,形态不同于软玻璃膜疣和视网膜下玻璃膜疣样沉积。
  • 厚玻璃膜疣与脉络膜增厚及脉络膜血管改变相关,遗传观察提示其为AMD谱系中独立亚型。
  • 厚玻璃膜疣进展至晚期AMD的临床意义需进一步阐明。

核心结论

  • 厚玻璃膜疣是与弥漫性或局限性脉络膜增厚相关的独立玻璃膜疣亚型,但不一定与弥漫性增厚相关。
  • 认识厚玻璃膜疣凸显了在AMD研究与管理中考虑遗传背景、种族和脉络膜特征的重要性。

研究设计与样本

  • 国际专家小组系统综述现有关于厚玻璃膜疣特征、患病率和临床关联的文献。
  • 通过结构化分析不同人群的形态学特征、诊断标准和临床结局制定共识声明。

主要发现

  • 厚玻璃膜疣形态上不同于软玻璃膜疣和视网膜下玻璃膜疣样沉积,表现为≥125 μm、边界清晰的不规则多小叶黄白色沉积。
  • 遗传观察提示厚玻璃膜疣为年龄相关性黄斑变性(AMD)谱系中的独立亚型。
  • 厚玻璃膜疣患病率随种族显著变化。
  • 厚玻璃膜疣常见于存在渗出的息肉状脉络膜血管病变和1型黄斑新生血管眼,但其存在并不一致地与渗出性改变风险增加相关,且罕进展为地图状萎缩。
  • 厚玻璃膜疣与脉络膜厚度增加及脉络膜血管改变相关。

关键数值与推荐

  • 厚玻璃膜疣定义为≥125 μm、边界清晰的不规则多小叶黄白色沉积。
  • 多模态影像可提供相关脉络膜特征的额外信息,但基于彩色眼底照相识别的标准化标准至关重要。
  • 厚玻璃膜疣进展至晚期AMD的风险需进一步阐明。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 厚玻璃膜疣进展至晚期AMD的临床意义需进一步阐明。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To establish evidence-based consensus statements on pachydrusen, a distinct drusen subtype associated with increased choroidal thickness, addressing current knowledge gaps in diagnosis, clinical significance, and management. METHODS: An international expert panel systematically reviewed existing literature on pachydrusen characteristics, prevalence, and clinical associations. Consensus statements were developed through structured analysis of morphologic features, diagnostic criteria, and clinical outcomes across diverse populations. RESULTS: Pachydrusen are morphologically distinct from soft drusen and subretinal drusenoid deposits, characterized by irregular, multilobulated yellow-white deposits ≥125 μm with sharp borders. The genetic observations suggest that pachydrusen represent a distinct subtype within the age-related macular degeneration (AMD) spectrum. Prevalence varies markedly by ethnicity. Pachydrusen are frequently observed in eyes with polypoidal choroidal vasculopathy and type 1 macular neovascularization when exudation is present, although their presence is not consistently associated with an increased risk of exudative change and they rarely progress to geographic atrophy. They are associated with increased choroidal thickness and choroidal vascular alterations. Although multimodal imaging may provide additional insights into associated choroidal features, standardized criteria for color fundus photography-based identification are essential. The clinical significance regarding progression risk to late AMD needs further elucidation. CONCLUSIONS: Pachydrusen are a distinct drusen subtype associated with generalized or localized choroidal thickening, but not necessarily with diffuse thickening. Recognition of pachydrusen highlights the importance of considering genetic background, ethnicity, and choroidal characteristics in AMD research and management.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Sasaki M, Apte RS, Bastion MC, et al. International Consensus and Guidelines on Diagnosing and Managing Pachydrusen from APVRS, AEEC, APOIS, AAPPO, and ARI. Am J Ophthalmol. 2025. PMID: 41086904. doi:10.1016/j.ajo.2025.10.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。